Mid Atlantic Retina

Clinical research site in Philadelphia, Pennsylvania · 743 N 24TH ST, PHILADELPHIA, PA 19130-2539 · (215) 763-3992 · Website

Part of Mid Atlantic Retina

As of July 2026, 5 paid clinical trials are recruiting at Mid Atlantic Retina in Philadelphia, Pennsylvania. Active studies at this site cover conditions such as Geographic Atrophy Secondary to Age-related Macular Degeneration, Neovascular Age-related Macular Degeneration and Geographic Atrophy. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Mid Atlantic Retina (5)

A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio

for Geographic Atrophy Secondary to Age-related Macular Degeneration

78 locations incl. Gilbert

Sponsor: Apellis Pharmaceuticals, Inc.

Sex: All·Age: 60+

Code: NCT07215390·Phase 2·Recruiting·Listed Oct 2025

Apply to this trial

Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)

for Neovascular Age-related Macular Degeneration

51 locations incl. Mesa

Sponsor: AbbVie

Sex: All·Age: 50+

Code: NCT07007065·Phase 3·Recruiting·Listed Jun 2025

Apply to this trial

A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration

for Geographic Atrophy Secondary to Age-related Macular Degeneration

15 locations incl. Huntington Beach

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 50+

Code: NCT07441642·Phase 2·Recruiting·Listed Mar 2026

Apply to this trial

A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (GAlette); Adaptive Optics (AO) Retinal Imaging Substudy in Association With Study GR44251

for Geographic Atrophy

15 locations incl. Beverly Hills

Sponsor: Genentech, Inc.

Sex: All·Age: 50+

Code: NCT05626114·Phase 2·Recruiting·Listed Nov 2022

Apply to this trial

A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration

for Age-Related Macular Degeneration

12 locations incl. Los Angeles

Sponsor: Astellas Institute for Regenerative Medicine

Sex: All·Age: 50+

Code: NCT03178149·Phase 1·Recruiting·Listed Jun 2017

Apply to this trial

More research sites in Philadelphia

University of Pennsylvania (357 trials)
Children's Hospital of Philadelphia (306 trials)
Thomas Jefferson University Hospital (112 trials)
Thomas Jefferson University (95 trials)
Fox Chase Cancer Center (94 trials)
Hospital of the University of Pennsylvania (87 trials)
The Children's Hospital of Philadelphia (42 trials)
Temple University (39 trials)
Temple University Hospital (38 trials)
University of Pennsylvania/Abramson Cancer Center (30 trials)

Explore more

Paid clinical trials in Philadelphia, PA · Pennsylvania clinical trials